'Designer Baby' Gets Go-Ahead (UK)
By Deutsche Welle,
Deutsche Welle
| 09. 10. 2004
British legislation allows the use of embryos in stem cell therapy
A couple in Northern Ireland have been permitted under a recent law in Great Britain to pursue the process which would lead to the first "designer baby," an embryo which would provide cells that could help treat the family's seriously ill three-year-old son.
To look at Joshua Fletcher, one would not see any signs of the illness. But he has a rare and potentially fatal blood disease called Diamond Blackfan anemia. In two years time, Joshua will be too old for the stem-cell therapy which could keep him alive. So for his parents, news that the treatment has been authorized is like the revocation of a death sentence.
"The chances are 95 percent in favor that Joshua with be cured by this therapy," said his father, Joe Fletcher. "If we do not do this, he will soon die." This new chance of life will come from an artificially created embryo, designed to provide cells for Joshua which in turn will produce the healthy red blood cells that will keep him alive.
The possible treatment was made a reality in the...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Miguel Muñoz, Cadena SER | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...